AIM logo

AIM ImmunoTech (AIM) Operating Profit

Annual Operating Profit

-$31.92 M
-$11.99 M-60.20%

December 31, 2023


Summary


Performance

AIM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherAIMprofitabilitymetrics:

Quarterly Operating Profit

-$4.49 M
-$795.00 K-21.52%

September 30, 2024


Summary


Performance

AIM Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherAIMprofitabilitymetrics:

TTM Operating Profit

-$27.92 M
+$3.67 M+11.61%

September 30, 2024


Summary


Performance

AIM TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherAIMprofitabilitymetrics:

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

AIM Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-60.2%+67.9%+12.5%
3 y3 years-112.5%+17.8%-27.9%
5 y5 years-177.6%+17.8%-27.9%

AIM Operating Profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-87.1%at low-42.4%+67.9%-69.6%+16.3%
5 y5-year-156.5%at low-45.4%+67.9%-124.4%+16.3%
alltimeall time-3091.6%at low-741.3%+67.9%-1429.6%+16.3%

AIM ImmunoTech Operating Profit History

DateAnnualQuarterlyTTM
Sep 2024
-
-$4.49 M(+21.5%)
-$27.92 M(-11.6%)
Jun 2024
-
-$3.69 M(-35.6%)
-$31.59 M(-5.3%)
Mar 2024
-
-$5.73 M(-59.1%)
-$33.36 M(+4.5%)
Dec 2023
-$31.92 M(+60.2%)
-$14.00 M(+71.7%)
-$31.92 M(+36.0%)
Sep 2023
-
-$8.16 M(+49.4%)
-$23.47 M(+7.5%)
Jun 2023
-
-$5.46 M(+27.1%)
-$21.83 M(+3.6%)
Mar 2023
-
-$4.29 M(-22.7%)
-$21.07 M(+5.7%)
Dec 2022
-$19.92 M(+16.8%)
-$5.56 M(-14.8%)
-$19.92 M(-0.5%)
Sep 2022
-
-$6.52 M(+38.9%)
-$20.03 M(+14.9%)
Jun 2022
-
-$4.70 M(+49.0%)
-$17.44 M(+5.9%)
Mar 2022
-
-$3.15 M(-44.4%)
-$16.46 M(-3.5%)
Dec 2021
-$17.06 M(+13.6%)
-$5.67 M(+44.2%)
-$17.06 M(+4.0%)
Sep 2021
-
-$3.93 M(+5.7%)
-$16.41 M(+3.6%)
Jun 2021
-
-$3.72 M(-0.7%)
-$15.83 M(+2.4%)
Mar 2021
-
-$3.75 M(-25.3%)
-$15.46 M(+2.8%)
Dec 2020
-$15.02 M(+20.7%)
-$5.01 M(+49.5%)
-$15.04 M(+14.7%)
Sep 2020
-
-$3.35 M(+0.4%)
-$13.11 M(+1.2%)
Jun 2020
-
-$3.34 M(+0.5%)
-$12.96 M(+0.9%)
Mar 2020
-
-$3.33 M(+7.7%)
-$12.84 M(+3.2%)
Dec 2019
-$12.44 M(+8.2%)
-$3.09 M(-3.7%)
-$12.44 M(+3.6%)
Sep 2019
-
-$3.21 M(-0.6%)
-$12.02 M(+1.4%)
Jun 2019
-
-$3.22 M(+10.2%)
-$11.85 M(-0.0%)
Mar 2019
-
-$2.93 M(+10.0%)
-$11.85 M(+3.1%)
Dec 2018
-$11.50 M(+0.7%)
-$2.66 M(-12.4%)
-$11.50 M(-1.1%)
Sep 2018
-
-$3.04 M(-5.9%)
-$11.63 M(+3.4%)
Jun 2018
-
-$3.23 M(+25.6%)
-$11.24 M(+4.6%)
Mar 2018
-
-$2.57 M(-8.0%)
-$10.74 M(-5.9%)
Dec 2017
-$11.42 M(-17.3%)
-$2.79 M(+5.3%)
-$11.42 M(-10.2%)
Sep 2017
-
-$2.65 M(-2.9%)
-$12.71 M(-4.3%)
Jun 2017
-
-$2.73 M(-15.8%)
-$13.28 M(-0.6%)
Mar 2017
-
-$3.24 M(-20.7%)
-$13.37 M(-3.2%)
Dec 2016
-$13.80 M(-17.1%)
-$4.08 M(+26.6%)
-$13.80 M(+9.9%)
Sep 2016
-
-$3.23 M(+14.6%)
-$12.56 M(-5.7%)
Jun 2016
-
-$2.81 M(-23.5%)
-$13.32 M(-13.5%)
Mar 2016
-
-$3.68 M(+29.4%)
-$15.41 M(-7.5%)
Dec 2015
-$16.65 M(-12.8%)
-$2.84 M(-28.6%)
-$16.65 M(-9.4%)
Sep 2015
-
-$3.98 M(-18.7%)
-$18.38 M(-1.8%)
Jun 2015
-
-$4.90 M(-0.4%)
-$18.73 M(-1.0%)
Mar 2015
-
-$4.92 M(+7.7%)
-$18.91 M(-1.0%)
Dec 2014
-$19.10 M(+11.3%)
-$4.57 M(+5.6%)
-$19.10 M(+6.5%)
Sep 2014
-
-$4.33 M(-14.9%)
-$17.94 M(-0.7%)
Jun 2014
-
-$5.08 M(-0.5%)
-$18.07 M(+2.0%)
Mar 2014
-
-$5.11 M(+49.8%)
-$17.72 M(+3.2%)
Dec 2013
-$17.17 M(-15.6%)
-$3.41 M(-23.5%)
-$17.17 M(-21.1%)
Sep 2013
-
-$4.46 M(-5.8%)
-$21.75 M(-2.3%)
Jun 2013
-
-$4.73 M(+3.8%)
-$22.26 M(+5.2%)
Mar 2013
-
-$4.56 M(-42.9%)
-$21.16 M(+4.0%)
Dec 2012
-$20.34 M(+42.3%)
-$8.00 M(+61.0%)
-$20.34 M(+25.2%)
Sep 2012
-
-$4.96 M(+36.7%)
-$16.25 M(+9.5%)
Jun 2012
-
-$3.63 M(-3.0%)
-$14.84 M(+2.7%)
Mar 2012
-
-$3.75 M(-3.9%)
-$14.45 M(+1.1%)
Dec 2011
-$14.29 M(-12.8%)
-$3.90 M(+9.6%)
-$14.29 M(-6.3%)
Sep 2011
-
-$3.56 M(+9.5%)
-$15.25 M(-0.9%)
Jun 2011
-
-$3.25 M(-9.5%)
-$15.38 M(-3.3%)
Mar 2011
-
-$3.59 M(-26.0%)
-$15.90 M(-2.9%)
Dec 2010
-$16.39 M(+23.5%)
-$4.85 M(+31.4%)
-$16.39 M(+5.7%)
Sep 2010
-
-$3.69 M(-2.0%)
-$15.51 M(+8.6%)
Jun 2010
-
-$3.77 M(-7.5%)
-$14.27 M(-1.4%)
Mar 2010
-
-$4.07 M(+2.5%)
-$14.48 M(+9.2%)
DateAnnualQuarterlyTTM
Dec 2009
-$13.26 M(+3.5%)
-$3.97 M(+61.7%)
-$13.26 M(+8.1%)
Sep 2009
-
-$2.46 M(-38.2%)
-$12.28 M(-7.5%)
Jun 2009
-
-$3.98 M(+39.5%)
-$13.27 M(+6.8%)
Mar 2009
-
-$2.85 M(-4.4%)
-$12.42 M(-3.1%)
Dec 2008
-$12.81 M(-33.6%)
-$2.98 M(-13.5%)
-$12.81 M(-7.4%)
Sep 2008
-
-$3.45 M(+10.3%)
-$13.84 M(-16.5%)
Jun 2008
-
-$3.13 M(-3.5%)
-$16.57 M(-5.8%)
Mar 2008
-
-$3.25 M(-19.1%)
-$17.59 M(-8.8%)
Dec 2007
-$19.29 M(+3.2%)
-$4.01 M(-35.1%)
-$19.29 M(-2.1%)
Sep 2007
-
-$6.18 M(+48.6%)
-$19.70 M(+13.3%)
Jun 2007
-
-$4.16 M(-15.8%)
-$17.38 M(-3.7%)
Mar 2007
-
-$4.94 M(+11.8%)
-$18.05 M(-3.5%)
Dec 2006
-$18.69 M(+88.5%)
-$4.42 M(+14.4%)
-$18.70 M(+7.6%)
Sep 2006
-
-$3.86 M(-19.9%)
-$17.38 M(+10.6%)
Jun 2006
-
-$4.83 M(-13.6%)
-$15.71 M(+17.5%)
Mar 2006
-
-$5.59 M(+80.0%)
-$13.37 M(+34.8%)
Dec 2005
-$9.91 M(-8.9%)
-$3.10 M(+41.5%)
-$9.92 M(+14.1%)
Sep 2005
-
-$2.19 M(-11.7%)
-$8.69 M(-5.7%)
Jun 2005
-
-$2.48 M(+16.3%)
-$9.21 M(+3.2%)
Mar 2005
-
-$2.13 M(+13.6%)
-$8.92 M(-18.1%)
Dec 2004
-$10.89 M(+50.2%)
-$1.88 M(-30.7%)
-$10.89 M(-3.4%)
Sep 2004
-
-$2.71 M(+23.6%)
-$11.27 M(+9.2%)
Jun 2004
-
-$2.19 M(-46.5%)
-$10.32 M(+5.7%)
Mar 2004
-
-$4.10 M(+81.6%)
-$9.76 M(+34.6%)
Dec 2003
-$7.25 M(+9.5%)
-$2.26 M(+27.9%)
-$7.25 M(+15.8%)
Sep 2003
-
-$1.77 M(+7.9%)
-$6.26 M(-1.8%)
Jun 2003
-
-$1.64 M(+2.8%)
-$6.38 M(-4.9%)
Mar 2003
-
-$1.59 M(+25.7%)
-$6.70 M(+1.3%)
Dec 2002
-$6.62 M(-24.8%)
-$1.27 M(-32.7%)
-$6.62 M(-5.7%)
Sep 2002
-
-$1.88 M(-4.1%)
-$7.02 M(-4.2%)
Jun 2002
-
-$1.96 M(+30.2%)
-$7.32 M(-5.7%)
Mar 2002
-
-$1.51 M(-9.4%)
-$7.76 M(-11.8%)
Dec 2001
-$8.80 M(-2.7%)
-$1.66 M(-23.9%)
-$8.80 M(-9.0%)
Sep 2001
-
-$2.19 M(-9.0%)
-$9.68 M(-0.0%)
Jun 2001
-
-$2.40 M(-5.7%)
-$9.68 M(+2.2%)
Mar 2001
-
-$2.55 M(+0.5%)
-$9.47 M(+4.7%)
Dec 2000
-$9.04 M(-29.2%)
-$2.54 M(+16.0%)
-$9.04 M(-22.3%)
Sep 2000
-
-$2.19 M(-0.3%)
-$11.64 M(+1.4%)
Jun 2000
-
-$2.19 M(+3.3%)
-$11.48 M(-4.2%)
Mar 2000
-
-$2.12 M(-58.6%)
-$11.99 M(-6.6%)
Dec 1999
-$12.78 M(+77.5%)
-$5.13 M(+152.7%)
-$12.83 M(+33.7%)
Sep 1999
-
-$2.03 M(-24.7%)
-$9.60 M(+3.6%)
Jun 1999
-
-$2.70 M(-9.0%)
-$9.27 M(+12.1%)
Mar 1999
-
-$2.97 M(+56.3%)
-$8.27 M(+19.8%)
Dec 1998
-$7.20 M(+12.5%)
-$1.90 M(+11.7%)
-$6.90 M(+4.5%)
Sep 1998
-
-$1.70 M(0.0%)
-$6.60 M(+3.1%)
Jun 1998
-
-$1.70 M(+6.3%)
-$6.40 M(+10.3%)
Mar 1998
-
-$1.60 M(0.0%)
-$5.80 M(-12.1%)
Dec 1997
-$6.40 M(+33.3%)
-$1.60 M(+6.7%)
-$6.60 M(+3.1%)
Sep 1997
-
-$1.50 M(+36.4%)
-$6.40 M(0.0%)
Jun 1997
-
-$1.10 M(-54.2%)
-$6.40 M(+1.6%)
Mar 1997
-
-$2.40 M(+71.4%)
-$6.30 M(+37.0%)
Dec 1996
-$4.80 M(+380.0%)
-$1.40 M(-6.7%)
-$4.60 M(-27.0%)
Sep 1996
-
-$1.50 M(+50.0%)
-$6.30 M(+53.7%)
Jun 1996
-
-$1.00 M(+42.9%)
-$4.10 M(+70.8%)
Mar 1996
-
-$700.00 K(-77.4%)
-$2.40 M(+140.0%)
Dec 1995
-$1.00 M
-$3.10 M(-542.9%)
-$1.00 M(-147.6%)
Sep 1995
-
$700.00 K(0.0%)
$2.10 M(+50.0%)
Jun 1995
-
$700.00 K(0.0%)
$1.40 M(+100.0%)
Mar 1995
-
$700.00 K
$700.00 K

FAQ

  • What is AIM ImmunoTech annual operating income?
  • What is the all time high annual operating profit for AIM ImmunoTech?
  • What is AIM ImmunoTech annual operating profit year-on-year change?
  • What is AIM ImmunoTech quarterly operating income?
  • What is the all time high quarterly operating profit for AIM ImmunoTech?
  • What is AIM ImmunoTech quarterly operating profit year-on-year change?
  • What is AIM ImmunoTech TTM operating income?
  • What is the all time high TTM operating profit for AIM ImmunoTech?
  • What is AIM ImmunoTech TTM operating profit year-on-year change?

What is AIM ImmunoTech annual operating income?

The current annual operating profit of AIM is -$31.92 M

What is the all time high annual operating profit for AIM ImmunoTech?

AIM ImmunoTech all-time high annual operating income is -$1.00 M

What is AIM ImmunoTech annual operating profit year-on-year change?

Over the past year, AIM annual operating income has changed by -$11.99 M (-60.20%)

What is AIM ImmunoTech quarterly operating income?

The current quarterly operating profit of AIM is -$4.49 M

What is the all time high quarterly operating profit for AIM ImmunoTech?

AIM ImmunoTech all-time high quarterly operating income is $700.00 K

What is AIM ImmunoTech quarterly operating profit year-on-year change?

Over the past year, AIM quarterly operating income has changed by +$9.52 M (+67.94%)

What is AIM ImmunoTech TTM operating income?

The current TTM operating profit of AIM is -$27.92 M

What is the all time high TTM operating profit for AIM ImmunoTech?

AIM ImmunoTech all-time high TTM operating income is $2.10 M

What is AIM ImmunoTech TTM operating profit year-on-year change?

Over the past year, AIM TTM operating income has changed by +$4.00 M (+12.52%)